Table IV.
Analyte | Calibration range (nM) | Model | Weighting | LOQ (nM) | LOD (nM) | Correlation (R2) | Origin |
---|---|---|---|---|---|---|---|
Metodesnitazene | 0.5–50 | Quadratic | 1/x2 | 0.5 | 0.1 | 0.998 | Excluded |
Flunitazene | 0.5–50 | Quadratic | 1/x2 | 0.5 | 0.1 | 0.999 | Excluded |
Metonitazene | 0.5–50 | Quadratic | 1/x2 | 0.5 | 0.05 | 0.998 | Excluded |
Etodesnitazene | 0.5–50 | Quadratic | 1/x | 0.5 | 0.01 | 0.997 | Excluded |
Etonitazepyne | 0.5–50 | Quadratic | 1/x2 | 0.5 | 0.01 | 0.999 | Excluded |
Clonitazene | 0.1–50 | Quadratic | 1/x2 | 0.1 | 0.02 | 0.999 | Excluded |
Etonitazene | 0.5–50 | Quadratic | 1/x2 | 0.5 | 0.02 | 0.999 | Excluded |
Isotonitazene | 0.1–50 | Quadratic | 1/x2 | 0.1 | 0.02 | 0.998 | Excluded |
Protonitazene | 0.5–50 | Quadratic | 1/x | 0.5 | 0.1 | 0.999 | Excluded |